Cargando…

Cancer vaccines: the importance of targeting oncogenic drivers and the utility of combinations with immune checkpoint inhibitors

Detalles Bibliográficos
Autores principales: Crosby, Erika J., Lyerly, H. Kim, Hartman, Zachary C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7800770/
https://www.ncbi.nlm.nih.gov/pubmed/33456706
http://dx.doi.org/10.18632/oncotarget.27861
_version_ 1783635425662861312
author Crosby, Erika J.
Lyerly, H. Kim
Hartman, Zachary C.
author_facet Crosby, Erika J.
Lyerly, H. Kim
Hartman, Zachary C.
author_sort Crosby, Erika J.
collection PubMed
description
format Online
Article
Text
id pubmed-7800770
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-78007702021-01-15 Cancer vaccines: the importance of targeting oncogenic drivers and the utility of combinations with immune checkpoint inhibitors Crosby, Erika J. Lyerly, H. Kim Hartman, Zachary C. Oncotarget Editorial Impact Journals LLC 2021-01-05 /pmc/articles/PMC7800770/ /pubmed/33456706 http://dx.doi.org/10.18632/oncotarget.27861 Text en Copyright: © 2021 Crosby et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Editorial
Crosby, Erika J.
Lyerly, H. Kim
Hartman, Zachary C.
Cancer vaccines: the importance of targeting oncogenic drivers and the utility of combinations with immune checkpoint inhibitors
title Cancer vaccines: the importance of targeting oncogenic drivers and the utility of combinations with immune checkpoint inhibitors
title_full Cancer vaccines: the importance of targeting oncogenic drivers and the utility of combinations with immune checkpoint inhibitors
title_fullStr Cancer vaccines: the importance of targeting oncogenic drivers and the utility of combinations with immune checkpoint inhibitors
title_full_unstemmed Cancer vaccines: the importance of targeting oncogenic drivers and the utility of combinations with immune checkpoint inhibitors
title_short Cancer vaccines: the importance of targeting oncogenic drivers and the utility of combinations with immune checkpoint inhibitors
title_sort cancer vaccines: the importance of targeting oncogenic drivers and the utility of combinations with immune checkpoint inhibitors
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7800770/
https://www.ncbi.nlm.nih.gov/pubmed/33456706
http://dx.doi.org/10.18632/oncotarget.27861
work_keys_str_mv AT crosbyerikaj cancervaccinestheimportanceoftargetingoncogenicdriversandtheutilityofcombinationswithimmunecheckpointinhibitors
AT lyerlyhkim cancervaccinestheimportanceoftargetingoncogenicdriversandtheutilityofcombinationswithimmunecheckpointinhibitors
AT hartmanzacharyc cancervaccinestheimportanceoftargetingoncogenicdriversandtheutilityofcombinationswithimmunecheckpointinhibitors